Cipla Q2 Profit Falls 35% Despite Record India Sales
Cipla shares closed lower on 27 October, after a day high of Rs 1,372.70, as the firm posted a 35% drop in Q2 profit. Cipla...
Tag : Qilu Pharmaceutical
Cipla Bags Exclusive US Rights for Keytruda Biosimilar
Cipla InvaGen signed an exclusive deal with Qilu Pharmaceutical to license QL2107, a Keytruda biosimilar, in the US. For those wondering what a biosimilar actually...